The evolution of device technology in transcatheter aortic valve implantation
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
The evolution of device technology in transcatheter aortic valve implantation. / Bourantas, Christos V; Modolo, Rodrigo; Baumbach, Andreas; Søndergaard, Lars; Prendergast, Bernard D; Ozkor, Muhidin; Kennon, Simon; Mathur, Anthony; Mullen, Michael J; Serruys, Patrick W.
I: EuroIntervention, Bind 14, Nr. 18, 2019, s. e1826-e1833.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The evolution of device technology in transcatheter aortic valve implantation
AU - Bourantas, Christos V
AU - Modolo, Rodrigo
AU - Baumbach, Andreas
AU - Søndergaard, Lars
AU - Prendergast, Bernard D
AU - Ozkor, Muhidin
AU - Kennon, Simon
AU - Mathur, Anthony
AU - Mullen, Michael J
AU - Serruys, Patrick W
PY - 2019
Y1 - 2019
N2 - Transcatheter aortic valve implantation (TAVI) has rapidly evolved and changed the landscape of structural interventional cardiology. Advances in transcatheter heart valve (THV) prostheses and TAVI-enabling devices have simplified the procedure, reduced the risk of complications, improved short- and long-term outcomes and broadened the applications of TAVI, not only in challenging patients and complex anatomies but also in intermediate-risk or even in low-risk patients, where surgical valve replacement constitutes an effective and well-established therapy. In this review article, we provide an overview of the developments in TAVI devices which have played a vital role in TAVI evolution: we describe the prostheses that failed to reach clinical practice, we present the characteristics of the first valves that were tested in the clinical arena, we summarise the evidence from the first studies that highlighted the potential but also the limitations of TAVI, and we present the advanced next-generation THV prostheses that have an improved performance and safety profile.
AB - Transcatheter aortic valve implantation (TAVI) has rapidly evolved and changed the landscape of structural interventional cardiology. Advances in transcatheter heart valve (THV) prostheses and TAVI-enabling devices have simplified the procedure, reduced the risk of complications, improved short- and long-term outcomes and broadened the applications of TAVI, not only in challenging patients and complex anatomies but also in intermediate-risk or even in low-risk patients, where surgical valve replacement constitutes an effective and well-established therapy. In this review article, we provide an overview of the developments in TAVI devices which have played a vital role in TAVI evolution: we describe the prostheses that failed to reach clinical practice, we present the characteristics of the first valves that were tested in the clinical arena, we summarise the evidence from the first studies that highlighted the potential but also the limitations of TAVI, and we present the advanced next-generation THV prostheses that have an improved performance and safety profile.
KW - Aortic Valve
KW - Aortic Valve Stenosis
KW - Heart Valve Prosthesis
KW - Humans
KW - Transcatheter Aortic Valve Replacement
KW - Treatment Outcome
U2 - 10.4244/EIJ-D-18-01048
DO - 10.4244/EIJ-D-18-01048
M3 - Review
C2 - 30719977
VL - 14
SP - e1826-e1833
JO - EuroIntervention
JF - EuroIntervention
SN - 1774-024X
IS - 18
ER -
ID: 241012963